Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 10/20 | 0.43 |
| ▸ | NPY1R | P25929 | 7/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.34 |
| ▸ | NPY2R | P49146 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.32 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.32 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13949746 | 1.00 | NPY4R (0.43) | NPY4RNPY1RFOLH1ALOX15NPY5R | |
| SCHEMBL23048407 | 1.00 | NPY4R (0.43) | NPY4RNPY1RFOLH1ALOX15NPY5R | |
| Hydrochloric Acid SCHEMBL28825330 | 0.98 | NPY4R (0.43) | NPY4RNPY1RFOLH1ALOX15NPY5R | |
| Hydrochloric Acid SCHEMBL7303864 | 0.98 | NPY4R (0.43) | NPY4RNPY1RFOLH1ALOX15NPY5R | |
| Hydrochloric Acid SCHEMBL7302869 | 0.98 | NPY4R (0.43) | NPY4RNPY1RFOLH1ALOX15NPY5R | |
| SCHEMBL2521911 | 0.95 | NPY4R (0.43) | NPY4RNPY1RFOLH1ALOX15NPY5R | |
| SCHEMBL16263594 | 0.90 | NPY4R (0.49) | NPY4RNPY1RFOLH1NPY5RNPY2R | |
| SCHEMBL27554606 | 0.88 | CAD (0.39) | NPY4RNPY1RALOX15NPY5RNPY2R | |
| SCHEMBL8019370 | 0.88 | CAD (0.39) | NPY4RNPY1RALOX15NPY5RNPY2R | |
| SCHEMBL18671700 | 0.86 | NPY4R (0.47) | NPY4RNPY1RFOLH1NPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2371421-A1 | Ligands of insulin degrading enzyme and their uses | Université de Lille 2 Droit et Santé (FR) | 2011-10-05 | — | — | EP | disclosed |
| US-20100087466-A1 | NOVEL SMALL MOLECULE DNAK INHIBITORS | CHAPERONE TECHNOLOGIES, INC. | 2010-04-08 | — | — | US | disclosed |
| EP-1046392-A2 | Cosmetic and dermatologic compositions for improving the skin barrier function | Beiersdorf AG (DE) | 2000-10-25 | — | — | EP | disclosed |
| EP-0969790-A2 | COMPOSITIONS FOR TREATING ACNE ROSACEA | Beiersdorf Aktiengesellschaft (DE) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998036730-A2 | COMPOSITIONS FOR TREATING ACNE ROSACEA | BEIERSDORF AG (DE) | 1998-08-27 | — | — | WO | disclosed |
| US-5389614-A | Anticoagulants | CASSELLA AG (DE) | 1995-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087466-A1 | NOVEL SMALL MOLECULE DNAK INHIBITORS | HSP90AB2P, HSPH1, HSP90AB1 | NPY4R 4813/4885NPY1R 4671/4885FOLH1 3002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.